# A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome

> **NCT02701985** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 75 (actual)

## Conditions studied

- Sjogren's Syndrome

## Interventions

- **DRUG:** Placebo
- **DRUG:** RO5459072

## Key facts

- **NCT ID:** NCT02701985
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-07-05
- **Primary completion:** 2017-07-10
- **Final completion:** 2017-07-10
- **Target enrollment:** 75 (ACTUAL)
- **Last updated:** 2018-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02701985

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02701985, "A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02701985. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*